Palobiofarma receives milestone payment from Novartis

por Palobiofarma

The milestone payment is the first from the licensing agreement between the two companies. Under the terms of that agreement, which was signed in September 2015, Novartis has exclusive development and...

Leer más
Subscribirse al Directorio
Escribir un Artículo

Últimas Noticias

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...

Destacadas

Entrevista con Dámaso Molero, director ...

by 3P Biopharmaceuticals

Dámaso Molero:" Creo que en Latinoamérica habrá negocio en el d...

Smart4Fabry final workshop, 3rd February...

by Institute for Advanced Chemistry of Catalonia (IQAC-CSIC)

Smart4Fabry is the acronym of a H2020 funded Project that stands for ...

Diapositiva de Fotos